argenx, a clinical-stage biotechnology company has announced an exclusive, global collaboration and license agreement fo...
Editas Medicine, a genome editing company has announced results from experiments to demonstrate expanded CRISPR genome e...
Auris Health, Inc. has announced the close of a $220 million equity financing led by Partner Fund Management. New invest...
Biocartis Group NV, an innovative molecular diagnostics company, has entered into an agreement with AstraZeneca, a globa...
The U.S. Food and Drug Administration has approved Firdapse (amifampridine) tablets for the treatment of Lambert-Eaton m...
Jecure Therapeutics Inc., a biotechnology company with novel drug discovery programs targeting serious inflammatory dise...
GE Healthcare has announced the opening of a biotechnology manufacturing centre at the Stevenage Bioscience Catalyst (SB...
Pharma company, Incyte has announced the appointment of Dashyant Dhanak as Executive Vice President and Chief Scientific...
US based pharma company Roivant Sciences and Cincinnati Children’s Hospital Medical centre has announced...
Frazier Healthcare Partners has announced Mimi Hancock, Ph.D. has joined its Life Sciences team as a Senior Advisor to a...
Receptor Life Sciences has announced the appointment of Orrin Devinsky, M.D., as the company’s Chief Medical Offic...
The World Health Organization (WHO) has launched a new community-driven platform - the Knowledge Action Portal (KAP) - f...
CURE Pharmaceutical, an innovative drug delivery and development company, has secured a new registration with the Drug E...
U.S. based Kronos Bio has announced that it has appointed Philip Gutry as its Chief Business Officer. In this newly cre...
Merck Foundation, the philanthropic arm of Merck Germany underscored their commitment to build healthcare capacity in th...
Aspen Pharmacare, South Africa’s leading JSE-listed pharmaceutical company, is pleased to announce the launch of E...
Clinical-stage gene therapy company Axovant has announced the addition of five senior team members to strengthen its exp...
First-ever multi drug trial for an Ebola treatment has been announced by The Ministry of Health of the Democratic Republ...
REGENXBIO Inc, a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of...
Singapore –Cobra Biologics, an international contract development and manufacturing organization (CDMO) ...
Santhera Pharmaceuticals which is Swiss specialty pharmaceutical company focused on the development and commercializatio...
An investment firm focused on the North American manufacturing sector, Altus Capital Partners has announced that it has ...
Synthego, the leading provider of genome engineering products, and Eurofins Genomics, a global leader in bioanalytical t...
Singapore - Mylan N.V. announced that its U.S. based Mylan Pharmaceuticals business is conducting a voluntary nationwide...
Eureka Therapeutics has announced publication in Cell Discovery validating its ARTEMIS antibody-TCR (AbTC...
Notable leadership change comes as Brickell prepares to progress its lead product candidate, sofpironium bromide, to Pha...
Researchers at the National Centre for Complementary and Integrative Health (NCCIH), part of the National Institutes of ...
Images from the world's first full-body 3D medical scanner named EXPLORER have been released. This scanner is developed ...
Danish dermatology specialists LEO Pharma and California based company PellePharm has announced a strategic development ...
The development of new medical products that are considered the highest priority for people in developing countries is h...
With the new parallel imaging method CAIPIRINHA, Mark Griswold, Peter Jakob and their colleagues have taken the technolo...
US based clinical-stage biotechnology company Magenta Therapeutics has announced that it has strengthened its executive ...
In order to scale up prevention and treatment, and increased investment, to protect vulnerable people from Malaria, WHO ...
LimaCorporate is pleased to announce that Michel Orsinger, Board Member of LimaCorporate's Advisory Board, will ass...
Sandoz, a Novartis division, and Pear Therapeutics, Inc., has announced the commercial launch of reSET for patients with...
Merck and Pfizer Inc. announced that the Phase III JAVELIN Ovarian 200 trial evaluating avelumab* alone or in combinatio...
Forbion, a leading European life science venture capital firm has announced that it has led a Series B financing round o...
The World Health Organization (WHO) is shifting its focus towards active screening of girls and women of childbearing ag...
Agilent Technologies Inc. has announced the opening of a new, purpose-built extension to its Little Island, Cork facilit...
Mission Therapeutics, a drug discovery and development company focused on selectively targeting deubiquitylating enzymes...
Vyera Pharmaceuticals, LLC has announced that it plans to initiate a Phase 1 single ascending dose (SAD) study of ...
Singapore - Citing the sharp rise in youth use of e-cigarettes, FDA Commissioner Scott Gottlieb, M.D. announces&nbs...
Singapore - Aimed at trimming annual operating expenses by $100M - 150M and boosting performance, Boston Scientific will...
ADC Biotechnology (ADC Bio), announces that it has secured additional funding of £2.5 million from existing invest...
Singapore - Exscientia, the company leading the use of Artificial Intelligence (AI) in drug discovery, announces that is...
Singapore - A California jury clears Johnson & Johnson of liability in a case involving a woman who alleged tha...
Singapore - BC Platforms, a world leader in secure genomic data management and analytics, announces an agreement with Na...
Novartis’ Sandoz division recently announced that it was no longer pursuing US approval for Rixathon, its biosimil...
Grunenthal has acquired the US-based pharmaceutical company Averitas Pharma, thereby extending its commercial footprint ...
Geneious Biologics, an enterprise software solution for companies engaged in screening of antibodies and antibody-like m...
Singapore – Amgen announced the final results from a five-year open-label study evaluating the abil...
Singapore – P-E player Veritas Capital and hedge fund Elliott Management have teamed to purchase Athenahealth...
According to a recent survey conducted by the World Health Organization (WHO), antibiotics are used far more in some cou...
Thermo Fisher Scientific Inc., the world leader in serving science, has elected Jim Mullen to its board of directors. Mu...
Jazz Pharmaceuticals plc announced that the National Institute for Health and Care Excellence (NICE) has publ...
AbbVie has announced patent license agreements with Momenta over its proposed biosimilar adalimumab product. Under the t...
Oncology Analytics, a leading technology-enabled service company which provides health plans, providers and patients wit...
A group of scientists from Rutgers University-New Brunswick Rutgers has created a tiny, biodegradable scaffold to transp...
Merck, the vibrant science and technology company, has launched its new BioContinuum Platform to advance biotherapeutic ...
Genetics can be used to predict a patient's response to antipsychotic drug treatment for schizophrenia, according to a r...
Singapore - In the future, cyberattackers may be able to exploit memory implants to steal, spy on, alter or control huma...
Pfizer recently announced that the U.S. Food and DrugAdministration (FDA) has aproved LORBRENA a third-generation ...
Amsterdam-based BioGX B.V., a subsidiary of Birmingham, Alabama based molecular diagnostics company BioGX, ann...
Agilent Technologies Inc. has introduced the Cary 3500 UV-Vis system, an innovative spectrophotometer designed to help l...
Sandoz, a Novartis division and the pioneer and global leader in biosimilars, has announced that the US Food and Drug Ad...
Singapore - The FDA approves a consumer-targeted molecular diagnostic test from privately held 23andme, t...
The US FDA is taking new steps to foster innovation in the emerging space of plant and animal biotechnology. The FDA has...
OpGen, Inc. has announced a collaboration with QIAGEN N.V. to advance rapid diagnostics for antimicrobial resistance (AM...
Orchard Therapeutics plc a biopharmaceutical company dedicated to transforming the lives of patients with serious and li...
Singapore – The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food and D...
Singapore – Halozyme has out-licensed its ENHANZE drug delivery technology to Roche for the exclusi...
Informa plc has appointed Adam Andersen Group Director of the Pharma Portfolio (previously part of UBM), which includes ...
Thermo Fisher Scientific, the world leader in serving science, and Symphogen, a clinical-stage antibody oncology-focused...
Singapore – The FDA grants 510(k) clearance for Bio-Rad Laboratories' IH-Reader 24, a semi-automated blo...
Singapore – Aimed at satisfying European Commission (EC) concerns about the potential overlap in the inflammatory ...
EBD Group (EBD), the market-leading provider of world-class partnering events and tools for the global life science...
Elpis Biomed Ltd. (Elpis), a University of Cambridge spin-out developing high quality human cells via its proprietary OP...
M3 Biotechnology, a Seattle-based therapeutics company dedicated to developing, first-in-class, therapies for Alzhe...
ICON plc, (NASDAQ: ICLR) a global provider of drug development services to the pharmaceutical, biotechnology and me...
Bain Capital and Pfizer have announced the creation of Cerevel Therapeutics, a new biopharmaceutical company...
AstraZeneca, and its global biologics research and development arm MedImmune, have announced a new multi-term agreement ...
Singapore – A non-opioid drug developed by Pfizer and Eli Lilly met the main go...
Synthego, a leading genome engineering innovation company, today announced a $110 million Series C financing round led b...
Kibow Biotech is proud to announce its 21st year of operations as a pioneer with the use of Pro/Prebiotics in people wit...
Congenica, the global diagnostic decision support platform provider, announced a key partnership with the UK’s&nbs...
Stream Bio Ltd, a company that develops and manufactures a range of revolutionary bioimaging molecular probes, is expand...
AstraZeneca and Merck have announced detailed results from the Phase III SOLO-1 trial testing Lynparza (...
Singapore - The FDA approves Regeneron Pharmaceuticals and development partner Sanofi's DUPIXENT (dupilumab) a...
Singapore - Results from a Phase 3 clinical trial, IMpassion130, evaluating Roche unit Genentech's TECENTRIQ (...
Luminex has signed a definitive agreement to buy MilliporeSigma’s flow cytometry portfolio for $75 million. This ...
Recruitment and retention in clinical studies for Alzheimer’s disease remains one of the biggest hurdles in the pa...
apceth Biopharma GmbH, a company with the mission of improving patients’ lives with next generation cell therapies...
Adapt Pharma, maker of the naloxone nasal spray Narcan used for the emergency treatment of known or suspected opioid ove...
RepliCel Life Sciences Inc., a company developing next-generation technologies in aesthetics and orthopedics, announces ...
Acticor Biotech, a clinical stage biotechnology company involved in the acute phase of thrombotic diseases, including st...
Arcis Biotechnology, the nucleic acid sample preparation solution provider has announced that it has signed a technology...
For a quarter century, the Beckman Coulter name has been important to clinicians and researchers worldwide. For the latt...
US based Co-Diagnostics, Inc., a molecular diagnostics company with a unique, proprietary platform for the development o...
Singapore - Axsome Therapeutics, a clinical-stage biopharmaceutical company developing novel therapies for the mana...
Singapore - Merck, known as MSD outside the United States and Canada, announced the appointment of Jim Scholefield as ch...
